Skip to main content
CJC-1295 Online

An online reading room for the CJC-1295 research record — the GHRH analog, its DAC variant, and the pharmacokinetics that separate them.

02 / amounts and shots in studies

CJC-1295 Was Tested at Different Amounts and Intervals

Studies measured hormones after different amounts and gaps between shots. The findings below concern people or animals. The study amounts do not set a human dose for your care.

People and Mice Received Different Amounts in Early Studies

Blood hormone levels rose after CJC-1295 shots in early research. In 2006, stage 1 work by Teichman tested early human safety. ConjuChem's stage 2 trial was meant to test benefit for abnormal fat changes. The later trial stopped without proving benefit.

In 2006, healthy adults received single skin shots at increasing amounts. Other adults received repeated weekly shots or shots every second week [3]. After one shot, raised growth hormone levels lasted six days, sometimes longer. The liver hormone stayed high between nine and eleven days. With repeated shots, the raised liver hormone level lasted through 28 days [3].

The ConjuChem stage 2 trial increased amounts in two groups. One group progressed through 60, 90, 120 micrograms for every kilogram the person weighed. The other progressed through 60, 120, 240 micrograms for each kilogram. Micrograms measure tiny weights; kilograms measure the person's body weight. Shots were weekly and beneath the skin [9]. The stopped trial didn't establish that the substance improved the patients' health [5][9].

In 2006, Alba tested mice missing the body's starting hormone. Each shot contained 2 micrograms, a tiny weight. Shots were 24 or 48 hours apart, or had 72-hour gaps. Over five weeks, the daily shots restored the mice's growth best [8].

The studies leave your safe human dose unsettled.

The Linked Form Was Studied With Longer Gaps Between Shots

CJC-1295-DAC, the linked form, remains in blood over several days. Stage 1 early safety tests and stage 2 benefit tests gave shots once or twice weekly. Growth hormone stayed raised between those study shots. The liver hormone that supports growth remained raised too [3][9]. Completed trials haven't tested longer gaps between shots.

Time in blood doesn't settle safe shot timing for your treatment.

Modified GRF names the CJC-1295 form without the link. Half the unlinked form leaves blood in roughly 30 minutes. Research accounts describe daily skin shots, sometimes given before bed [10]. Some accounts describe two or three shots each day. The aim was to follow the gland's usual hormone bursts.

In 2006, Alba tested mice receiving daily 2 microgram shots. Micrograms measure tiny weights. The mice reached normal length and weight with daily shots. Spacing shots 48 or 72 hours apart gave poorer growth results [8].

Those sick mice can't establish safe timing for shots in people.

CJC-1295 Blood Levels Fall by Half Over Minutes or Days

In 2006, Teichman measured how long CJC-1295-DAC stayed in healthy adults' blood. Half the linked form left the blood over several days [3]. Half the unlinked form left in about 30 minutes [10]. The linked substance and blood protein weigh about 67 kilodaltons. Kilodaltons measure tiny weights beyond an ordinary scale's reach. Joining protects the substance from breakdown and makes kidney filtering impossible [1].

Time Left in Blood Explains the Reported Gaps Between Shots

Research accounts gave the linked form once or twice weekly [3][9]. The unlinked form appears in accounts of daily or bedtime shots. The unlinked form was intended to follow brief hormone bursts [10]. Neither set of accounts establishes safe timing for your own care.

The Linked Form Was Studied With Longer Gaps Between Shots

CJC-1295 With Ipamorelin Has No Completed Human Benefit Trial

Researchers discuss pairing CJC-1295 with ipamorelin because their starting steps differ. Each prompts hormone-making cells at a different point. Early tests found a greater growth hormone rise together than separately [12]. That finding explains research interest, without proving health benefits.

People trying the pair outside controlled trials describe both CJC-1295 forms. Reported amounts were 100-300 micrograms, a tiny weight of substance. The accounts describe both substances given together in skin shots [12]. No completed stage 2 benefit test or larger stage 3 trial compared the pair with placebo in people. Placebo is a comparison treatment without the substances being tested. Pairing reports come from personal accounts and animal tests. A controlled human trial hasn't checked those reports.

In 1998, Raun's animal tests examined ipamorelin's effects on hormone release [12]. Much less ipamorelin was needed to release growth hormone than to release another hormone responsible for cortisol release. Cortisol is a stress hormone. This difference explains interest in pairing ipamorelin with CJC-1295, without proving benefit for you.

Published Human Trials Gave Shots Beneath the Skin

Published human CJC-1295 studies tested shots beneath the skin [13]. Every stage 1 safety test and stage 2 benefit test used that method. The main early animal studies used skin shots too. The swallowed substance is broken down by chemicals in the stomach. The swallowed substance can't reach blood intact. Researchers have explored nose delivery for related substances. Published human studies haven't established nose delivery for CJC-1295 [13].

Limited early animal research also tested delivery through a vein [3].

The added link attaches to blood protein once in circulation. Joining holds the substance longer and protects against breakdown. Skin shots allow time for the substance to reach blood and join that protein [1]. These findings describe research. The findings aren't shot instructions for your care.

Product Papers Do Not Establish Safe Human Mixing

Product papers describe water added to dried CJC-1295 powder for research. Some describe CJC-1295 alone; others describe a bottle with ipamorelin too. The water contains an added substance that slows germ growth. Papers describe 1-3 milliliters, a small measure of water. The handling is clean, with gentle swirling rather than shaking. Shaking can damage the chain of protein building blocks. Papers describe refrigerator storage at 2-8 degrees celsius [14]. Celsius measures temperature; these temperatures are above freezing. Single-use insulin syringes separate small amounts of the mixture. Water amounts depend on how much substance the bottle holds. Neither substance has a medically reviewed human mixing standard [14].

Product papers don't prove that preparation is safe for you.

Papers say mixed CJC-1295 lasts roughly 30 days under refrigeration. Dried CJC-1295 is stored at -20 degrees celsius, colder than freezing water [14]. Swallowing doesn't deliver the intact substance into blood. Most details come from research product papers. There is no FDA-approved medicine leaflet explaining preparation. These descriptions aren't mixing instructions for your treatment.